{
  "trial_id": "NCT02642159",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), baseline non-HDL-C levels, baseline LDL-C levels, baseline triglycerides levels, baseline HbA1c, history of atherosclerotic cardiovascular disease (ASCVD), cardiovascular risk factors, baseline use of antihyperglycemic agents, baseline use of statins, baseline use of other lipid-modifying therapies, alcohol consumption, weight change in the last 3 months.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Non-HDL-C",
          "baseline non-HDL-C levels"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Intent to Prescribe Treatment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "baseline LDL-C levels",
        "baseline triglycerides levels",
        "baseline HbA1c",
        "history of atherosclerotic cardiovascular disease (ASCVD)",
        "cardiovascular risk factors",
        "baseline use of antihyperglycemic agents",
        "baseline use of statins",
        "baseline use of other lipid-modifying therapies",
        "alcohol consumption",
        "weight change in the last 3 months."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Non-HDL Cholesterol, Triglycerides, Low-Density Lipoprotein Cholesterol, Apolipoprotein B, Total Cholesterol, High-Density Lipoprotein Cholesterol, Glycemic Parameters, Cardiovascular Disease History, Statin Therapy Dosage, Use of Antihyperglycemic Agents,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Non-HDL-C",
          "Non-HDL Cholesterol"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Intent to Prescribe Treatment"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Body Mass Index",
        "Baseline HbA1c",
        "Triglycerides",
        "Low-Density Lipoprotein Cholesterol",
        "Apolipoprotein B",
        "Total Cholesterol",
        "High-Density Lipoprotein Cholesterol",
        "Glycemic Parameters",
        "Cardiovascular Disease History",
        "Statin Therapy Dosage",
        "Use of Antihyperglycemic Agents"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Duration, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, LDL-C, Non-HDL-C, Triglycerides, HDL-C, Apolipoprotein B, Lipoprotein a, Total Cholesterol.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Non-HDL-C",
          "Non-HDL-C"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Intent to Prescribe Treatment"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diabetes Duration",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "HbA1c",
        "LDL-C",
        "Triglycerides",
        "HDL-C",
        "Apolipoprotein B",
        "Lipoprotein a",
        "Total Cholesterol."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), type 2 diabetes duration, atherosclerotic cardiovascular disease (ASCVD) status, cardiovascular risk factors, statin type and dose, non-HDL-C, LDL-C, HDL-C, triglycerides, lipoprotein a, apolipoprotein B, apolipoprotein A-1, glycosylated hemoglobin (HbA1c), anti-hyperglycemic agents, insulin use, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Non-HDL-C",
          "non-HDL-C"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Intent to Prescribe Treatment"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "type 2 diabetes duration",
        "atherosclerotic cardiovascular disease (ASCVD) status",
        "cardiovascular risk factors",
        "statin type and dose",
        "LDL-C",
        "HDL-C",
        "triglycerides",
        "lipoprotein a",
        "apolipoprotein B",
        "apolipoprotein A-1",
        "glycosylated hemoglobin (HbA1c)",
        "anti-hyperglycemic agents",
        "insulin use",
        "smoking status"
      ]
    }
  }
}